Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT02234960
Eligibility Criteria:
Inclusion Criteria:
* participants at least 18 years of age
* a diagnosis of moderate to severe RA
* treating physician has made the decision to commence tocilizumab in first line biologic treatment (population of DMARDs inadequate responders or participants who are intolerant to DMARDs) in a routine clinical practice in Poland
* informed consent
Exclusion Criteria:
N/A
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02234960
Study Brief:
Protocol Section:
NCT02234960